Paul T. Heath

Paul T. Heath

St George's University Of London
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 285 publications

Report from the inaugural 2025 Asia-UK Maternal-Neonatal Infection and Immunity Network (AMMuNet) symposium.

Report from the inaugural 2025 Asia-UK Maternal-Neonatal Infection and Immunity Network (AMMuNet) symposium.

Journal: NPJ vaccines

Published: June 11, 2026

Hypervirulent serogroup W meningococcal strain belonging to the ST-11 clonal complex is associated with higher case fatality rates: nationwide cohort study of invasive meningococcal disease caused by serogroup W in England from 2010-2019.

Hypervirulent serogroup W meningococcal strain belonging to the ST-11 clonal complex is associated with higher case fatality rates: nationwide cohort study of invasive meningococcal disease caused by serogroup W in England from 2010-2019.

Journal: The Journal of infection

Published: May 11, 2026

Baseline adverse birth outcomes in a prospective pregnancy cohort in Uganda: Evidence to inform maternal vaccine readiness.

Baseline adverse birth outcomes in a prospective pregnancy cohort in Uganda: Evidence to inform maternal vaccine readiness.

Journal: Vaccine

Published: March 23, 2026

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.

Journal: Vaccine

Published: March 19, 2026

Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.

Safety and immunogenicity of GBS6 in pregnant women living with and without HIV and their infants in Uganda (PREPARE WP4): a double-blind, randomised, placebo-controlled, phase 2 clinical trial.

Journal: The Lancet. Infectious diseases

Published: March 06, 2026

COVID-19 Hospitalisations in women of childbearing age and children during the Omicron period, January 2023 to September 2024.

COVID-19 Hospitalisations in women of childbearing age and children during the Omicron period, January 2023 to September 2024.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 03, 2026

Maternal Group B Streptococcus Vaccination: A Three-Country European Consortium to Improve Surveillance and Data Readiness.

Maternal Group B Streptococcus Vaccination: A Three-Country European Consortium to Improve Surveillance and Data Readiness.

Journal: Clinical epidemiology

Published: January 30, 2026

Current knowledge and future perspectives on management and prevention of group B streptococcus in neonates and young infants.

Current knowledge and future perspectives on management and prevention of group B streptococcus in neonates and young infants.

Journal: Archives of disease in childhood. Fetal and neonatal edition

Published: November 28, 2025

A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis.

A rapid time-resolved host gene expression signature predicts responses to antibiotic treatment in neonatal bacterial sepsis.

Journal: Science translational medicine

Published: November 26, 2025

Methodological framework for the surveillance of healthcare-associated infections in high-risk infants: the NeoIPC surveillance core module protocol.

Methodological framework for the surveillance of healthcare-associated infections in high-risk infants: the NeoIPC surveillance core module protocol.

Journal: Antimicrobial resistance and infection control

Published: October 30, 2025

Human Cytomegalovirus (HCMV) Shedding and T-cell Immune Responses in HCMV-seropositive Women During Pregnancy and Postpartum: Prevalence, Natural History, and Risk Factors.

Human Cytomegalovirus (HCMV) Shedding and T-cell Immune Responses in HCMV-seropositive Women During Pregnancy and Postpartum: Prevalence, Natural History, and Risk Factors.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 19, 2025

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Immunogenicity, reactogenicity, and safety of a reduced-interval 4CMenB primary immunisation schedule in UK infants: a multicentre, open-label, assessor-blinded, phase 4 randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: October 06, 2025

Showing 1-12 of 285

Last Updated: 09/26/2026